CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
Abstract Immune checkpoint blockade (ICB) improves outcomes in non-small cell lung cancer (NSCLC) though most patients progress. There are limited data regarding molecular predictors of progression. In particular, there is controversy regarding the role of CDKN2A loss-of-function (LOF) in ICB resist...
Guardado en:
Autores principales: | Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr, Sherin J. Rouhani, Carolina Soto Chervin, George Steinhardt, Angela M. Lager, Pankhuri Wanjari, Renuka Malik, Philip P. Connell, Steven J. Chmura, Aditya Juloori, Philip C. Hoffman, Mark K. Ferguson, Jessica S. Donington, Jyoti D. Patel, Everett E. Vokes, Ralph R. Weichselbaum, Christine M. Bestvina, Jeremy P. Segal, Sean P. Pitroda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82195ffa5c7b45b097938796d4698839 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Ashutosh Kumar Arya, et al.
Publicado: (2017) -
Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui X, et al.
Publicado: (2021) -
Miz1 is a critical repressor of cdkn1a during skin tumorigenesis.
por: Jan Hönnemann, et al.
Publicado: (2012) -
A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis
por: Paul Krimpenfort, et al.
Publicado: (2019) -
Methods to optimize energy consumption in Conarc furnaces
por: Aashay Wanjari
Publicado: (2021)